$95.00
Tanya Rivera (Editor)
Series: Military and Veteran Issues
BISAC: PSY022040
The Department of Defense (DOD) and the Department of Veterans Affairs’ (VA) Veterans Health Administration (VHA) have collaborated to develop clinical practice guidelines for post-traumatic stress disorder (PTSD) and mild traumatic brain injury (TBI). Medication continuation, when clinically appropriate, is critical for transitioning servicemembers with PTSD or TBI who have been prescribed psychiatric, pain, or sleep medications. Adverse health effects may occur if these medications are inappropriately discontinued. This book examines the extent to which DOD and VHA developed and monitored recommended medication practices for PTSD and TBI; the extent to which psychiatric, pain, and sleep medications on DOD’s formulary are on VA’s formulary, and how differences might affect medication continuation; and key efforts VHA has to help ensure medication continuation, and the extent it is monitoring these efforts. (Imprint: Novinka)
Table of Contents
Preface
Chapter 1. DOD and VA Health Care: Actions Needed to Help Ensure Appropriate Medication Continuation and Prescribing Practices
United States Government Accountability Office
Chapter 2. Clinician’s Guide to Medications for PTSD
Matt Jeffreys
Chapter 3. Defense Health Care: Research on Hyperbaric Oxygen Therapy to Treat Traumatic Brain Injury and Post-Traumatic Stress Disorder
United States Government Accountability Office
Index
We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!
